查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球數位醫療市場 - 2023-2030
市場調查報告書
商品編碼
1297773

全球數位醫療市場 - 2023-2030

Global Digital Health Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球數位健康市場在2022年達到2232億美元，預計到2030年將見證有利可圖的成長，達到8503億美元。在2023-2030年的預測期間，全球數位健康市場預計將呈現18.9%的複合成長率。越來越多的技術進步和新型產品的臨床試驗推動了數位健康市場的需求趨勢。

創新技術的發展，軟體和服務的進步，新更新的推出，以及需要病人監測的病人數量的增加，是推動全球數位健康市場的主要因素。

數位健康市場範圍包括組件、技術和終端用戶，增加了數位健康市場佔有率。全球數位健康市場正在擴大，原因包括不斷增加的研究和開發，他們即將在各國批准的新產品也為數位健康市場的成長創造了一個積極的前景。

市場動態

不斷增加的研究和開發以及新產品的推出推動了數位健康市場的成長。

儘管還沒有足夠的數據來支持其廣泛使用，但醫療機構正慢慢開始將可穿戴技術融入病人護理中。設備與輻射健康中心（CDRH）的數位健康卓越中心（DHCoE）旨在支持負責任的數位健康創新，保護和促進公共健康，包括科學研究和夥伴關係。

通過以數位健康為中心的合作，CDRH正在促進監管科學研究，這使得FDA專家能夠理解和評估與新興數位健康技術相關的優勢和風險。通過提供科學、公正和客觀的專業知識，這項研究有助於保證患者和消費者使用的商品的安全或減少其危害。

政府支持和計劃的增加為製造商創造了有利可圖的機會

政府支持和計劃的增加是推動數位醫療市場發展的主要因素。例如，歐盟委員會和世界衛生組織（WHO）在數位健康領域發起了一個歷史性的聯盟。

歐盟（EU）的數位COVID-19認證平台將於2023年6月被世衛組織採用，以建立一個全球系統，協助促進跨境流動，保障世界各地的人們免受目前和潛在的健康危險，如大流行病。世衛組織全球數位健康認證網路（GDHCN）將創建各種數位產品以促進全民健康的改善，這是其第一個基石。

該項目是在2022年11月30日特德羅斯博士和基里亞基德委員之間達成的協議之後進行的，目的是在全球健康問題上加強戰略合作。它取決於世衛組織和歐盟關於數位健康的全球衛生戰略。

與數位健康相關的劣勢將阻礙市場的成長。

應用程式內容像其他數位資訊一樣容易受到數據洩露和駭客攻擊。此外，一個應用程式可能會洩露用戶的隱私和個人數據。此外，行動應用程式中的內容比醫學期刊中的內容受到的監督要少。例如，它們在測量血壓時可能會產生錯誤的結果。

另一方面，技術本身也帶來了困難。無線連接、軟體和硬體都不是沒有錯誤的。它們可能會在虛擬測試的過程中突然停止工作。對於某些人來說，轉換到技術可能會帶來更大的挑戰。

關於遠程醫療和遠程保健活動，每個州都有自己的法律和準則。同樣，隨著我們對技術的依賴程度越來越高，人們越來越擔心細節是否安全，是否受到駭客和安全漏洞的保護。

COVID-19影響分析

COVID-19疫情和全球封鎖影響了所有行業企業的財務健康。因此，美國食品和藥物管理局（FDA）發布了COVID-19衛生緊急情況指南，包括協助贊助商和研究人員的一般注意事項，確保試驗參與者的安全，遵循良好的臨床實踐（GCP），並減少對試驗完整性的風險。

俄烏戰爭影響分析

俄羅斯-烏克蘭衝突估計對全球數位醫療市場的影響不大，因為該地區的主要市場參與者數量較少。然而，在預測期內，原料進出口的影響預計對全球數位健康市場的成長影響不大。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按組件分析
  • 按技術分類的摘要
  • 按終端用戶分類
  • 按地區分類

第四章：動態變化

  • 影響因素
    • 驅動因素
      • 遠程監控服務需求上升
      • 政府支持和計劃的增加
    • 限制因素
      • 與數位醫療相關的劣勢
    • 機會
      • 研究與開發和新產品發布的增加
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第7章：按組件分類

  • 硬體
  • 軟體
  • 服務

第8章：按技術分類

  • 移動醫療
    • 可穿戴設備
      • 血糖儀
      • 脈搏血氧儀
      • 心臟監測器
      • 呼吸暫停和睡眠監測器
      • 神經系統監測儀
      • 其他
    • 應用程式
      • 健美應用
      • 醫療應用
  • 電子健康
    • 電子病歷(EHR)
    • 供應商中立檔案（VNA）和圖片存檔與通訊系統（PACS）。
    • 實驗室資訊系統（LIS）
    • 處方解決方案
  • 遠程醫療
    • 遠程醫療
      • 影片諮詢
      • 長期護理監測
    • 遠程護理
      • 遠程用藥管理
      • 活動監測
  • 健康分析

第九章：按終端用戶分類

  • 醫療保健供應商
  • 醫療保健消費者
  • 其他用戶

第十章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
      • 亞太其他地區
  • 中東和非洲
    • 關鍵區域的動態

第11章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併和收購分析

第十二章：公司簡介

  • BioTelemetry, a Philips Company
    • 公司概述
    • 產品組合和描述
    • 財務概況
    • 主要發展情況
  • Veradigm LLC
  • EClinicalWorks
  • IHealth Labs Inc
  • Athenahealth Inc.
  • AT&T
  • Honeywell International Inc.
  • Cisco Systems, Inc.
  • AdvancedMD, Inc.
  • McKesson Corporation

第十三章：附錄

簡介目錄
Product Code: HCIT6461

Market Overview

The Global Digital Health Market reached US$ 223.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 850.3 billion by 2030. The Global Digital Health Market is expected to exhibit a CAGR of 18.9% during the forecast period 2023-2030. The increasing technological advancements and clinical trials for novel products drive demand for digital health market trends.

The development of innovative technologies, advancements in software and services, the launch of new updates, and an increase in a number of patients requiring patient monitoring are the main factors propelling the global market for digital health.

The Digital Health Market scope comprises components, technology and end-user, increasing the digital health market share. The global market for digital health is expanding due to factors including increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the digital health market growth.

Market Dynamics

Rising Research and Development and Novel Product Launches Drive the Growth of the Digital Health market.

Even though there isn't yet enough data to support its widespread use, healthcare is slowly beginning to integrate wearable technology in patient care. The Center for Devices and Radiological Health's (CDRH) Digital Health Center of Excellence (DHCoE) aims to support responsible digital health innovation and protect and promote public health, including scientific research and partnerships.

Through collaborations centered on digital health, CDRH is promoting regulatory science research, which allows FDA experts to comprehend and evaluate the advantages and risks associated with emerging digital health technologies. By offering scientific, unbiased, and objective expertise, this research helps guarantee the safety or lessen the harm related to goods used by patients and consumers.

Increased Government Support and Initiatives creates Lucrative Opportunities for Manufacturers

There are rising government support and initiatives are the major factors driving the growth of the digital health market. For instance, the European Commission and the World Health Organization (WHO) launched a historic alliance in digital health.

The European Union (EU) platform for digital COVID-19 certification will be adopted by WHO in June 2023 to create a global system that will aid in facilitating cross-border mobility and safeguarding people all over the world from present and potential health dangers, such as pandemics. The WHO Global Digital Health Certification Network (GDHCN), which will create various digital products to promote improved health for all, has this as its first cornerstone.

The project follows the 30 November 2022 deal between Dr. Tedros and Commissioner Kyriakides to increase strategic collaboration on global health concerns. It depends on the WHO and EU Global Health Strategy on Digital Health.

Disadvantages Associated with Digital Health will Hamper the Growth of the Market.

App content is vulnerable to data breaches and hackers like other digital information. Additionally, an app can divulge user data that is private and personal. Additionally, the content in mobile apps is less monitored than that found in medical journals. For instance, they might produce erroneous findings when measuring blood pressure.

On the other hand, technology itself presents difficulties. Wireless connections, software, and hardware are not error-free. They may stop working suddenly or in during the course of a virtual test. For certain individuals, converting to technology can potentially provide a greater challenge.

Regarding telemedicine and telehealth activities, each state has its own laws and guidelines. Again, there are growing worries about how secure and safeguarded details are from hackers and security breaches as we depend more heavily on technology.

COVID-19 Impact Analysis

The COVID-19 epidemic and the worldwide lockdown have affected the financial health of businesses in all industries. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the COVID-19 health emergency, including general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global digital health market, owing to the low number of key market players in this region. However, the effect of the import and export of raw materials is expected to have little influence over the Global Digital Health market growth over the forecast period.

Segment Analysis

The Global Digital Health Market is segmented based on component, technology, end user and region.

mHealth from Technology Accounts for 27.2% of Market Share Owing to Rising Utilization

Over the past year, the field of digital health has experienced tremendous growth. Electronic health, mobile health, and telehealth are all used to refer to the use of desktop and mobile technology for patient management. The phrase "mHealth," or "mobile health," implies the application of portable technologies, such as tablets and smartphones, to support medical processes.

Patients can log, save, and analyze their health data on their own mobile devices using mHealth services. These programs aid in increasing the effectiveness of the dissemination of medical information. Apps for mobile health may be useful for researchers, patients, and healthcare professionals.

Additionally, mobile health-tracking apps are becoming more widely used daily. There are more than 318,000 health applications available for download. GoogleFit, Fitbit, and Apple Heart Study are a few well-known mHealth app examples.

Geographical Analysis

North America Accounted for Approximately 45.3% of the Market Share Owing to the Strong Presence of Major Players and Rising Technological Advancements

Manufacturers have chances to expand their operations in this region because of the rising demand for digital health for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of digital health, increasing demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for novel technologies.

The market will grow as new components or technology for healthcare emerge. Rising technological developments, governmental approvals, and introducing new products all contribute to growth. People are becoming more aware of novel technologies and apps for digital healthcare, leading to the market expansion in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the digital health market include: BioTelemetry, a Philips Company, EClinicalWorks, Veradigm LLC, IHealth Labs Inc, AT&T, Athenahealth Inc., Honeywell International Inc., AdvancedMD, Inc., Cisco Systems, Inc. and McKesson Corporation among others.

Why Purchase the Report?

  • To visualize the Global Digital Health Market segmentation based on component, technology, end user and region, and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous digital health market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Digital Health Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Technology
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Remote Monitoring Services Demand
      • 4.1.1.2. Increased Government Support and Initiatives
    • 4.1.2. Restraints
      • 4.1.2.1. Disadvantages Associated with Digital Health
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Research and Development and Novel Product Launches
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Hardware *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Software
  • 7.4. Services

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. mHealth *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Wearables
      • 8.2.3.1. Blood Glucose Meter
      • 8.2.3.2. Pulse Oximetry
      • 8.2.3.3. Cardiac Monitors
      • 8.2.3.4. Apnea & Sleep Monitors
      • 8.2.3.5. Neurological Monitors
      • 8.2.3.6. Others
    • 8.2.4. Apps
      • 8.2.4.1. Fitness Apps
      • 8.2.4.2. Medical Apps
  • 8.3. eHealth
    • 8.3.1. Electronic Health Records (EHR)
    • 8.3.2. Vendor Neutral Archive (VNA) and Picture Archiving & Communications Systems (PACS)
    • 8.3.3. Laboratory Information Systems (LIS)
    • 8.3.4. Prescribing Solutions
  • 8.4. Telehealthcare
    • 8.4.1. Telehealth
      • 8.4.1.1. Video Consultation
      • 8.4.1.2. LTC Monitoring
    • 8.4.2. Telecare
      • 8.4.2.1. Remote Medication Management
      • 8.4.2.2. Activity Monitoring
  • 8.5. Health Analytics

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Healthcare Providers *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Healthcare Consumers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. BioTelemetry, a Philips Company *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Veradigm LLC
  • 12.3. EClinicalWorks
  • 12.4. IHealth Labs Inc
  • 12.5. Athenahealth Inc.
  • 12.6. AT&T
  • 12.7. Honeywell International Inc.
  • 12.8. Cisco Systems, Inc.
  • 12.9. AdvancedMD, Inc.
  • 12.10. McKesson Corporation

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us